My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1669

    1.

    Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.

    Kelley DE, Bray GA, Pi-Sunyer FX, Klein S, Hill J, Miles J, Hollander P.

    Diabetes Care. 2002 Jun;25(6):1033-41. Erratum in: Diabetes Care. 2003 Mar;26(3):971.. PMID: 12032111 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.

    Miles JM, Leiter L, Hollander P, Wadden T, Anderson JW, Doyle M, Foreyt J, Aronne L, Klein S.

    Diabetes Care. 2002 Jul;25(7):1123-8. Erratum in: Diabetes Care. 2002 Sep;25(9):1671.. PMID: 12087008 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

    Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, Weiss SR, Crockett SE, Kaplan RA, Comstock J, Lucas CP, Lodewick PA, Canovatchel W, Chung J, Hauptman J.

    Diabetes Care. 1998 Aug;21(8):1288-94.PMID: 9702435 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.

    Halpern A, Mancini MC, Suplicy H, Zanella MT, Repetto G, Gross J, Jadzinsky M, Barranco J, Aschner P, Ramirez L, Matos AG.

    Diabetes Obes Metab. 2003 May;5(3):180-8.PMID: 12681025 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Pharmacological therapy of obesity]

    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

    G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

    6.

    Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes.

    Shi YF, Pan CY, Hill J, Gao Y.

    Diabet Med. 2005 Dec;22(12):1737-43.PMID: 16401321 [PubMed - indexed for MEDLINE]Related articles

    7.

    The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial.

    Hanefeld M, Sachse G.

    Diabetes Obes Metab. 2002 Nov;4(6):415-23.PMID: 12406041 [PubMed - indexed for MEDLINE]Related articles

    8.

    A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin.

    Berne C; Orlistat Swedish Type 2 diabetes Study Group.

    Diabet Med. 2005 May;22(5):612-8.PMID: 15842517 [PubMed - indexed for MEDLINE]Related articles

    9.

    One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor.

    Finer N, James WP, Kopelman PG, Lean ME, Williams G.

    Int J Obes Relat Metab Disord. 2000 Mar;24(3):306-13.PMID: 10757623 [PubMed - indexed for MEDLINE]Related articles

    10.

    Orlistat in hypertensive overweight/obese patients: results of a randomized clinical trial.

    Bloch KV, Salles GF, Muxfeldt ES, Da Rocha Nogueira A.

    J Hypertens. 2003 Nov;21(11):2159-65.PMID: 14597860 [PubMed - indexed for MEDLINE]Related articles

    11.

    The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.

    Muls E, Kolanowski J, Scheen A, Van Gaal L; ObelHyx Study Group.

    Int J Obes Relat Metab Disord. 2001 Nov;25(11):1713-21.PMID: 11753595 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes.

    Kelley DE, Kuller LH, McKolanis TM, Harper P, Mancino J, Kalhan S.

    Diabetes Care. 2004 Jan;27(1):33-40.PMID: 14693963 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.

    Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J.

    Diabetes Obes Metab. 2000 Apr;2(2):105-12.PMID: 11220522 [PubMed - indexed for MEDLINE]Related articles

    14.

    The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.

    Tong PC, Lee ZS, Sea MM, Chow CC, Ko GT, Chan WB, So WY, Ma RC, Ozaki R, Woo J, Cockram CS, Chan JC.

    Arch Intern Med. 2002 Nov 25;162(21):2428-35.PMID: 12437401 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults.

    Heymsfield SB, Segal KR, Hauptman J, Lucas CP, Boldrin MN, Rissanen A, Wilding JP, Sjöström L.

    Arch Intern Med. 2000 May 8;160(9):1321-6.PMID: 10809036 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.

    Robinson AC, Burke J, Robinson S, Johnston DG, Elkeles RS.

    Diabetes Care. 1998 May;21(5):701-5.PMID: 9589227 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Bromocriptine: a novel approach to the treatment of type 2 diabetes.

    Pijl H, Ohashi S, Matsuda M, Miyazaki Y, Mahankali A, Kumar V, Pipek R, Iozzo P, Lancaster JL, Cincotta AH, DeFronzo RA.

    Diabetes Care. 2000 Aug;23(8):1154-61.PMID: 10937514 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.

    Herz M, Johns D, Reviriego J, Grossman LD, Godin C, Duran S, Hawkins F, Lochnan H, Escobar-Jiménez F, Hardin PA, Konkoy CS, Tan MH.

    Clin Ther. 2003 Apr;25(4):1074-95.PMID: 12809958 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.

    Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J.

    JAMA. 2005 Jun 15;293(23):2873-83. Erratum in: JAMA. 2005 Sep 28;294(12):1491. PMID: 15956632 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.

    Sjöström L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, Krempf M.

    Lancet. 1998 Jul 18;352(9123):167-72.PMID: 9683204 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity